Trodelvy 180 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FM2DQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,321
Award facts
- Contract value 100% obligated
- $14,320.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 12, 2026, for the supply of Trodelvy 180 mg vials with a firm fixed price ceiling value of $14,320.96 and an ultimate completion date of February 3, 2026. This is a non-set-aside contract awarded through competitive procurement. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp operates as a subsidiary of parent company Cencora, Inc. (UEI: NWEGNLYTBDW4), a major pharmaceutical distributor and healthcare solutions provider. The company serves as a critical vendor for federal medical procurement needs, supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The SPE2DX IDC with DLA Troop Support Medical represents a significant strategic contract vehicle, with the Defense Logistics Agency planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts that will make multiple awards for separate regions, potentially involving at least three different contractors.
Quick answers
Who was awarded contract SPE2DR26FM2DQ?
SPE2DR26FM2DQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26FM2DQ worth?
The government has obligated $14,321 on SPE2DR26FM2DQ.
Is contract SPE2DR26FM2DQ an order under another contract?
Yes. SPE2DR26FM2DQ is a delivery order under SPE2DR25D3501, an indefinite delivery contract.
Was contract SPE2DR26FM2DQ competed?
The extent of competition for SPE2DR26FM2DQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award